Peptide Biologix
Compound index
The atlas

Gonadorelin Technical Specification Sheet

Reproductive / Melanocortin · MW 1182.31 g/mol · GnRH, LHRH · Native hypothalamic decapeptide ligand for GnRH receptors on anterior pituitary gonadotrophs.

Engraved study of a small branching coral skeleton with fine surface ridges
Plate 12Gonadorelin
Primary Amino Acid Sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂

Molecular Properties

Parameter Value
Chemical Name Gonadotropin-Releasing Hormone / Luteinizing Hormone-Releasing Hormone (LHRH)
Amino Acid Sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
Molecular Formula C₅₅H₇₅N₁₇O₁₃
Molecular Weight 1182.31 g/mol
CAS Number 33515-09-2
Sequence Length 10 amino acids (decapeptide)
Receptor Target GnRH receptor (GnRHR) on pituitary gonadotrophs

Physical Properties

Property Specification
Appearance White to off-white lyophilized powder
Solubility Soluble in water, PBS (pH 7.0-7.4), or 0.9% saline at ≥1 mg/mL
pH (1% solution) 5.0 - 7.0
Hygroscopicity Low; standard desiccated storage acceptable
Solution Stability Stable at 4°C for 7-10 days; degradation at room temperature within 24-48h

Analytical Specifications

Test Specification
HPLC Purity ≥98.0%
Mass Spectrometry Confirmed [M+H]⁺ = 1182.31 ± 0.5 Da
Peptide Content ≥95% (by amino acid analysis)
Endotoxin Level <1.0 EU/mg
Acetate Content ≤5%
TFA Content ≤0.1%
Water Content ≤6% (Karl Fischer)

Storage Parameters

Condition Specification
Lyophilized Storage -20°C, desiccated
Lyophilized Shelf Life 24-36 months when stored properly
Reconstituted Storage 2-8°C for up to 10 days; -20°C for up to 3 months
Analytical Stock Preparation Dissolve in sterile water or PBS (pH 7.0-7.4) with gentle vortexing for 30 seconds
Freeze-Thaw Cycles Maximum 3 cycles; single-use aliquoting recommended
Light Sensitivity Minimal; standard laboratory storage acceptable

In Vitro & Preclinical Model Concentrations

Literature summary of published study doses, routes, and schedules.
Experimental Model Published Concentration / Regimen Exposure Schedule Administration Context
In Vitro Pituitary Cell Assays 1-100 nM Acute stimulation (minutes to hours) Culture media
Small Animal Models (Rodent) 10-100 μg/kg (10-100 nmol/kg) Single bolus or pulsatile (every 60-90 min) IV, SC, IP in rodent models
LH/FSH Stimulation Assay (Animal) 25-100 μg/kg Single bolus IV or SC in animal models
Reproductive Axis Studies (Animal) 0.1-10 μg/animal Pulsatile every 1-2 hours IV infusion pump or bolus in animal models

Note: Concentrations and animal regimens summarized above are for research reference only. Pulsatile delivery mimics physiological hypothalamic secretion patterns in experimental systems.

Key Research Studies

Year Study Focus Key Findings
1971 Discovery and characterization First isolation and sequencing of GnRH from porcine and ovine hypothalami; demonstrated decapeptide structure with pGlu N-terminus and Gly-NH₂ C-terminus critical for activity
1982 Pulsatile secretion pattern and receptor dynamics Established that pulsatile GnRH delivery (60-90 min intervals) maintains gonadotropin secretion while continuous administration causes receptor desensitization and downregulation within 7-14 days
1997 Structure-activity relationship Systematic amino acid substitutions revealed positions 1, 2, 3, 6, and 10 essential for receptor binding; modifications at positions 6 and 10 generated superagonists with 50-200x potency
2008 GnRH receptor signaling cascades Detailed GnRHR signaling via Gq/11 → PKC activation → Ca²⁺ mobilization → ERK1/2 phosphorylation pathway; demonstrated EC₅₀ of 0.5-2 nM for LH secretion from primary pituitary cells

Mechanism of Action

Biological Pathway Description
Receptor Binding Binds GnRH receptor (GnRHR), a Gq-coupled GPCR on anterior pituitary gonadotrophs; high affinity with Kd ~1-5 nM
Signal Transduction Activates phospholipase C → IP₃/DAG production → intracellular Ca²⁺ release → protein kinase C activation
Gonadotropin Secretion Stimulates rapid release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from gonadotrophs within 5-15 minutes
Pulsatile Requirement Physiological pulses every 60-120 minutes maintain LH/FSH; continuous exposure desensitizes receptors and suppresses gonadotropin output
Half-Life 2-4 minutes (IV); rapid degradation by hypothalamic and pituitary peptidases

Clinical Variants and Analogs

Type Examples Key Modification
Native GnRH Gonadorelin acetate Natural sequence; short half-life
Superagonists Triptorelin, Leuprolide, Goserelin Position 6 and 10 substitutions; extended half-life and potency
Antagonists Cetrorelix, Ganirelix, Degarelix Multiple D-amino acid substitutions; competitive receptor blockade
Diagnostic Forms Gonadorelin hydrochloride Alternative salt form for diagnostic testing; equivalent activity

Quality Control Parameters

Test Method Acceptance Criteria
Appearance (visual) White to off-white powder; no aggregation or discoloration
Reconstitution Test Complete dissolution within 1 minute; clear colorless solution
RP-HPLC (purity) Main peak ≥98.0%; no single impurity >0.5%
ESI-MS (identity) Observed [M+H]⁺ within ±0.05% of theoretical 1182.31 Da
Peptide Sequence Confirmation N-terminal pGlu and C-terminal Gly-NH₂ verified by MS/MS

Regulatory & Pharmaceutical History

Gonadorelin (as gonadorelin hydrochloride and gonadorelin acetate, under historical trade names including Factrel and Lutrepulse) has received FDA approval for diagnostic evaluation of hypothalamic-pituitary gonadotropic function and pulsatile induction of ovulation in primary hypothalamic amenorrhea. Research-grade gonadorelin documented in this monograph is intended strictly for in vitro and laboratory investigation.

External References

  1. Schally AV, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43(2):393-9. https://pubmed.ncbi.nlm.nih.gov/4930860/
  2. Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994;45:391-405. https://www.annualreviews.org/doi/10.1146/annurev.med.45.1.391
  3. National Center for Biotechnology Information. PubChem Compound Summary for Gonadorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Gonadorelin